Journal of Clinical Medicine of Kazakhstan
Online ISSN:
2313-1519
Print ISSN:
1812-2892
Journal of Clinical Medicine of Kazakhstan
HOME PAGE
ISSUES
CURRENT ISSUE
ARTICLES IN PRESS
ARCHIVE
ABOUT JOURNAL
Aims and Scope
Peer Review Process
Open Access Policy
Copyright and Permissions
Advertising and Marketing Policy
Archiving Policy
Indexing Information
Publisher Information
Journal History
ICJME Recommendations
COPE Guidelines
FOR AUTHORS
Instructions for Authors
Peer Review Policy
Publication Ethics
Research Ethics Policy
Corrections Retractions and Concerns
Article processing charges
Reporting Guidelines
Forms
EDITORIAL OFFICE
Governing Body
Editorial Board
Advisory Board
CONTACT
Online Submission System
Keyword:
hepatocellular carcinoma
Search Results (4)
Medico-social aspects of hepatocellular carcinoma
Niyaz Malayev, Samat Saparbayev, Saule Kubekova, Nurgul Kereyeva
J CLIN MED KAZ 2023; 20(3):4-7
DOI:
https://doi.org/10.23950/jcmk/13257
[PDF]
Invasive methods of hepatocellular carcinoma treatment
Инвазивные методы лечения гепатоцеллюлярной карциномы
Gulziya Ismailova, Eugene Yenin, Shokan Kaniev, Talgat Tajibaev, Altynshash Baichalova, Almat Chormanov, Bolatbek Baimakhanov
J CLIN MED KAZ 2017; 4(46):11-13
DOI:
https://doi.org/10.23950/1812-2892-JCMK-00468
[PDF]
Variations of angioarchitecture of the liver malignant tumors and its influence on the choice of the microspheres diameter.
Варианты ангиоархитектоники злокачественных новообразований печени и ее влияние на возможность выбора диаметра микросфер.
Turlybek Tuganbekov, Nasrulla Shanazarov, Niyaz Malayev
J CLIN MED KAZ 2015; 4(38):6-11
[PDF]
Development of adoptive immunotherapy technology in post-transplantation period
Освоение технологии адоптивной иммунотерапии в пост трансплантационный период.
Yuriy Kim, Samat Saparbayev, Bolatbek Kayupov, Zhuldyzay Kassymova, Aynara Darbayeva
J CLIN MED KAZ 2014; 2(32):73-75
[PDF]
Current Issue
Volume 21, Number 5 (2024)
Previous Issues
Articles in Press
This journal is licensed under the CC-BY Creative Commons Attribution 4.0 International License.